Vanderbilt investigators have discovered a new type of immune cell residing in the intestinal epithelium that may function as a first line of defense against ingested pathogens.
Vanderbilt investigators identify a new therapeutic target for the inflammatory lung disease sarcoidosis.
Understanding how the immune system responds to the respiratory virus HMPV is crucial for developing vaccines and anti-viral treatments.
Understanding how to control the generation of regulatory T cells could have important implications for treating autoimmunity and cancer.
Obesity causes peripheral immune cells to move to the brain, where they may contribute to inflammation and the pathophysiology of obesity.
A new in vitro system will allow investigators to explore how immune system T cells develop specialized functions.